Gene expression signature predicts recurrence in lung adenocarcinorna

被引:94
作者
Larsen, Jill E. [1 ]
Pavey, Sandra J.
Passmore, Linda H.
Bowman, Rayleen V.
Hayward, Nicholas K.
Fong, Kwun M.
机构
[1] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia
[2] Univ Queensland, Sch Med, Herston, Qld, Australia
[3] Queensland Inst Med Res, Human Genet Lab, Herston, Qld 4006, Australia
关键词
D O I
10.1158/1078-0432.CCR-06-2525
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Improving outcomes for early-stage lung cancer is a major research focus at present because a significant proportion of stage I patients develop recurrent disease within 5 years of curative-intent lung resection. Within tumor stage groups, conventional prognostic indicators' currently fail to predict relapse accurately. Experimental Design: To identify a gene signature predictive of recurrence in primary lung adenocarcinoma, we analyzed gene expression profiles in a training set of 48 node-negative tumors (stage I-II), comparing tumors from cases who remained disease-free for a minimum of 36 months with those from cases whose disease recurred within 18 months of complete resection. Results: Cox proportional hazards modeling with leave-one-out cross-validation identified a 54-gene signature capable of predicting risk of recurrence in two independent validation cohorts of 55 adenocarcinomas [log-rank P = 0.039; hazard ratio (HR), 2.2; 95% confidence interval (95% CI), 1.1-4.7] and 40 adenocarcinomas (log-rank P = 0.044; HR, 3.3; 95% Cl, 1.4-7.9). Kaplan-Meier log-rank analysis found that predicted poor-outcome groups had significantly shorter survival, and furthermore, the signature predicted outcome independently of conventional indicators of tumor stage and node stage. In a subset of earliest stage adenocarcinomas, generally expected to have good outcome, the signature predicted samples with significantly poorer survival. Conclusions: We describe a 54-gene signature that predicts the risk of recurrent disease independently of tumor stage and which therefore has potential to refine clinical prognosis for patients undergoing resection for primary adenocarcinoma of the lung.
引用
收藏
页码:2946 / 2954
页数:9
相关论文
共 47 条
[1]   K-ras mutations in non-small-cell lung carcinoma:: A review [J].
Aviel-Ronen, Sarit ;
Blackhall, Fiona H. ;
Shepherd, Frances A. ;
Tsao, Ming-Sound .
CLINICAL LUNG CANCER, 2006, 8 (01) :30-38
[2]   Semi-supervised methods to predict patient survival from gene expression data [J].
Bair, E ;
Tibshirani, R .
PLOS BIOLOGY, 2004, 2 (04) :511-522
[3]   Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence [J].
Baksh, FK ;
Dacic, S ;
Finkelstein, SD ;
Swalsky, PA ;
Raja, S ;
Sasatomi, E ;
Luketich, JD ;
Fernando, HC ;
Yousem, SA .
MODERN PATHOLOGY, 2003, 16 (01) :28-34
[4]   Classification, staging and prognosis of lung cancer [J].
Beadsmoore, CJ ;
Screaton, NJ .
EUROPEAN JOURNAL OF RADIOLOGY, 2003, 45 (01) :8-17
[5]   Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].
Beer, DG ;
Kardia, SLR ;
Huang, CC ;
Giordano, TJ ;
Levin, AM ;
Misek, DE ;
Lin, L ;
Chen, GA ;
Gharib, TG ;
Thomas, DG ;
Lizyness, ML ;
Kuick, R ;
Hayasaka, S ;
Taylor, JMG ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, S .
NATURE MEDICINE, 2002, 8 (08) :816-824
[6]   Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[7]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[8]   Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].
Buyse, Marc ;
Loi, Sherene ;
van't Veer, Laura ;
Viale, Giuseppe ;
Delorenzi, Mauro ;
Glas, Annuska M. ;
d'Assignies, Mahasti Saghatchian ;
Bergh, Jonas ;
Lidereau, Rosette ;
Ellis, Paul ;
Harris, Adrian ;
Bogaerts, Jan ;
Therasse, Patrick ;
Floore, Arno ;
Amakrane, Mohamed ;
Piette, Fanny ;
Rutgers, Emiel ;
Sotiriou, Christos ;
Cardoso, Fatima ;
Piccart, Martine J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192
[9]   Protein profiles associated with survival in lung adenocarcinoma [J].
Chen, GA ;
Gharib, TG ;
Wang, H ;
Huang, CC ;
Kuick, R ;
Thomas, DG ;
Shedden, KA ;
Misek, DE ;
Taylor, JMG ;
Giordano, TJ ;
Kardia, SLR ;
Iannettoni, MD ;
Yee, J ;
Hogg, PJ ;
Orringer, MB ;
Hanash, SM ;
Beer, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13537-13542
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187